Thin-Shelled PEGylated Perfluorooctyl Bromide Nanocapsules for Tumor-Targeted Ultrasound Contrast Agent

Figure 8

Echogenicity evaluation in subcutaneous lumps with two different concentrations of NCm100. THI-mode (left) and contrast mode (right) observation of two lumps with (a) high and (b) low concentrated NCm100. T, tumor.